|
"chong jen yu"的相關文件
顯示項目 1011-1035 / 1135 (共46頁)
<< < 36 37 38 39 40 41 42 43 44 45 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T07:20:09Z |
Lower gastrointestinal tract tuberculosis: An important but neglected disease
|
Lin, P.-Y. and Wang, J.-Y. and Hsueh, P.-R. and Lee, L.-N. and Hsiao, C.-H. and Yu, C.-J. and Yang, P.-C.; PO-REN HSUEH; LI-NA LEE; Chong-Jen Yu; JANN-YUAN WANG |
| 臺大學術典藏 |
2018-09-10T07:20:09Z |
Management of severe community-acquired septic meningitis in adults: From emergency department to intensive care unit
|
Hsu, C.-L. and Chang, C.-H. and Wong, K.-N. and Chen, K.-Y. and Yu, C.-J. and Yang, P.-C.; Chong-Jen Yu; CHIA-LIN HSU; CHIA-HSUIN CHANG |
| 臺大學術典藏 |
2018-09-10T07:20:09Z |
Mycobacterial arthritis of large joints
|
Shu, C.-C. and Wang, J.-Y. and Yu, C.-J. and Lee, L.-N.; CHIN-CHUNG SHU; LI-NA LEE; Chong-Jen Yu; JANN-YUAN WANG |
| 臺大學術典藏 |
2018-09-10T07:20:08Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow, C.-H.;Chang, Y.-L.;Hsu, Y.-C.;Tsai, M.-F.;Wu, C.-T.;Yu, C.-J.;Yang, C.-H.;Lee, Y.-C.;Yang, P.-C.;Shih, J.-Y.; CHEN-TU WU; YIH-LEONG CHANG; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T07:20:08Z |
Cooley's anemia
|
Kuo, C.-C. and Wang, J.-Y. and Tsai, C.-W. and Yu, C.-J.; Chong-Jen Yu; JANN-YUAN WANG |
| 臺大學術典藏 |
2018-09-10T07:20:08Z |
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment
|
Huang, C.-L.;Yang, C.-H.;Yeh, K.-H.;Hu, F.-C.;Chen, K.-Y.;Shih, J.-Y.;Lin, Z.-Z.;Yu, C.-J.;Cheng, A.-L.;Yang, P.-C.; Chong-Jen Yu; KUN-HUEI YEH; JIN-YUAN SHIH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:20:08Z |
Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis
|
Wang, J.-Y. and Lee, L.-N. and Yu, C.-J. and Chien, Y.-J. and Yang, P.-C.; LI-NA LEE; Chong-Jen Yu; JANN-YUAN WANG |
| 臺大學術典藏 |
2018-09-10T07:20:08Z |
Factors influencing visibility and diagnostic yield of transbronchial biopsy using endobronchial ultrasound in peripheral pulmonary lesions
|
Huang, C.-T. and Ho, C.-C. and Tsai, Y.-J. and Yu, C.-J. and Yang, P.-C.; CHUN-TA HUANG; CHONG-JEN YU; CHAO-CHI HO |
| 臺大學術典藏 |
2018-09-10T07:19:40Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho, C.-C. and Chen, Y.-C. and Hu, F.-C. and Yu, C.-J. and Yang, P.-C. and Luh, K.-T.; Chong-Jen Yu; CHAO-CHI HO; YEE-CHUN CHEN |
| 臺大學術典藏 |
2018-09-10T07:12:23Z |
Nontuberculous mycobacteria pulmonary infection in medical intensive care unit: The incidence, patient characteristics, and clinical significance
|
Shu, C.-C. and Lee, C.-H. and Wang, J.-Y. and Jerng, J.-S. and Yu, C.-J. and Hsueh, P.-R. and Lee, L.-N. and Yang, P.-C. and Wang, J.-Y. and Lee, L.-N. and Yu, C.-J. and Yang, P.-C. and Su, W.-J. and Shu, C.-C. and Lai, H.-C. and Lee, C.-H. and Yu, M.-C.; CHIN-CHUNG SHU; JIH-SHUIN JERNG; PO-REN HSUEH; LI-NA LEE; Chong-Jen Yu; JANN-YUAN WANG |
| 臺大學術典藏 |
2018-09-10T07:05:53Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
JIN-YUAN SHIH; PAN-CHYR YANG; Chong-Jen Yu; YIH-LEONG CHANG; Wu, S.-G. and Chang, Y.-L. and Hsu, Y.-C. and Wu, J.-Y. and Yang, C.-H. and Yu, C.-J. and Tsai, M.-F. and Shih, J.-Y. and Yang, P.-C. |
| 臺大學術典藏 |
2018-09-10T07:05:53Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu, J.-Y.; Wu, S.-G.; Yang, C.-H.; Gow, C.-H.; Chang, Y.-L.; Yu, C.-J.; Shin, J.-Y.; Yang, P.-C.; YIH-LEONG CHANG; CHONG-JEN YU; PAN-CHYR YANG |
| 臺大學術典藏 |
2018-09-10T07:01:39Z |
Small-cell lung carcinoma presenting with otalgia and hearing impairment
|
Kuo, Y.-W. and Chen, K.-Y. and Chang, Y.-L. and Lee, L.-N. and Yu, C.-J.; YIH-LEONG CHANG; LI-NA LEE; CHONG-JEN YU |
| 臺大學術典藏 |
2018-09-10T06:52:59Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma—A randomized phase II trial
|
Chiun Hsu and Sung-Hsin Kuo and Fu-Chang Hu and Ann-Lii Cheng and Jin-Yuan Shih and Chong-Jen Yu and Chia-Chi Lin and Tsu-Chen Huang and Pan-Chyr Yang and Chih-Hsin Yang; Chong-Jen Yu; Sung-Hsin Kuo; JIN-YUAN SHIH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T06:52:06Z |
Candida glabrata fungaemia in intensive care units
|
Ruan, S.-Y. and Lee, L.-N. and Jerng, J.-S. and Yu, C.-J. and Hsueh, P.-R.; PO-REN HSUEH; SHENG-YUAN RUAN; JIH-SHUIN JERNG; LI-NA LEE; Chong-Jen Yu |
| 臺大學術典藏 |
2018-09-10T06:51:41Z |
A patient with bronchiectasis presented with progressive dyspnoea and an unresolved right lower lung infiltrate
|
YANG, PAN-CHYR;LIN, PEI-YING;LEE, LI-NA;KU, SHIH-CHI;YAO, MING;YU, CHONG-JEN;楊泮池;姚明;林佩瑩;李麗娜;古世基;余忠仁;LI-NA LEE;SHIH-CHI KU;CHONG-JEN YU;MING YAO; LI-NA LEE; SHIH-CHI KU; CHONG-JEN YU; MING YAO; LIN, PEI-YING; YU, CHONG-JEN; YAO, MING; KU, SHIH-CHI; LEE, LI-NA; YANG, PAN-CHYR; �L�ؼ�; �E����; ����; �j�@��; ���R�R; ����� |
| 臺大學術典藏 |
2018-09-10T06:51:41Z |
Adrenal insufficiency in prolonged critical illness
|
SHIH-CHI KU;CHONG-JEN YU;CHAO-CHI HO; SHIH-CHI KU; CHONG-JEN YU; CHAO-CHI HO |
| 臺大學術典藏 |
2018-09-10T06:51:20Z |
Imprint cytology improves accuracy of computed tomography-guided percutaneous transthoracic needle biopsy
|
CHANG, YEUN-CHUNG;YU, CHONG-JEN;LEE, WEN-JENG;KUO, SOW-HSONG;HSIAO, CHENG-HSIANG;JAN, I-SHIOW;HU, FU-CHANG;LIU, HON-MAN;CHAN, WING-KAI;YANG, PAN-CHYR; YEUN-CHUNG CHANG; Chang, Y-C; Yu, C-J; Chong-Jen Yu; HON-MAN LIU; Lee, W-J; Kuo, S-H; I-SHIOW JAN; WEN-JENG LEE; Hsiao, C-H; Jan, I-S; Hu, F-C; Liu, H-M; Chane, W-K; Yang, P-C; Chang, Y-C; Yu, C-J; Lee, W-J; Kuo, S-H; Hsiao, C-H; Jan, I-S; Hu, F-C; Liu, H-M; Chane, W-K; Yang, P-C; 張允中;余忠仁;李文正;郭壽雄;蕭正祥;詹一秀;胡賦強;廖漢文;陳榮楷;楊泮池; Chang, Y.-C. and Yu, C.-J. and Lee, W.-J. and Kuo, S.-H. and Hsiao, C.-H. and Jan, I.-S. and Hu, F.-C. and Liu, H.-M. and Chan, W.-K. and Yang, P.-C. |
| 臺大學術典藏 |
2018-09-10T06:51:20Z |
First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer
|
Wu, J.-Y. and Yu, C.-J. and Yang, C.-H. and Wu, S.-G. and Chiu, Y.-H. and Gow, C.-H. and Chang, Y.-C. and Hsu, Y.-C. and Wei, P.-F. and Shih, J.-Y. and Yang, P.-C.; YEUN-CHUNG CHANG; Chong-Jen Yu; PAN-CHYR YANG; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T06:51:19Z |
Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response
|
Gow, C.-H. and Chien, C.-R. and Chang, Y.-L. and Chiu, Y.-H. and Kuo, S.-H. and Shih, J.-Y. and Chang, Y.-C. and Yu, C.-J. and Yang, C.-H. and Yang, P.-C.; YIH-LEONG CHANG; YEUN-CHUNG CHANG; Chong-Jen Yu; Sung-Hsin Kuo; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T06:51:18Z |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
|
JIN-YUAN SHIH; CHIA-TUNG SHUN; ANN-LII CHENG; Yang, C.-H. and Yu, C.-J. and Shih, J.-Y. and Chang, Y.-C. and Hu, F.-C. and Tsai, M.-C. and Chen, K.-Y. and Lin, Z.-Z. and Huang, C.-J. and Shun, C.-T. and Huang, C.-L. and Bean, J. and Cheng, A.-L. and Pao, W. and Yang, P.-C.; YEUN-CHUNG CHANG; Chong-Jen Yu; PAN-CHYR YANG |
| 臺大學術典藏 |
2018-09-10T06:48:35Z |
MicroRNA Signature Predicts Survival and Relapse in Lung Cancer
|
Chen, H.-Y.; Chang, G.-C.; Chen, C.-Y.; Chen, H.-W.; Singh, S.; Cheng, C.-L.; Yu, C.-J.; Lee, Y.-C.; Chen, H.-S.; Su, T.-J.; Chiang, C.-C.; Li, H.-N.; Hong, Q.-S.; Su, H.-Y.; Chen, C.-C.; Chen, W.-J.; Liu, C.-C.; Chan, W.-K.; Chen, W.J.; Li, K.-C.; Chen, J.J.W.; Yang, P.-C.; Yu, S.-L.; Yu, Sung-Liang; CHONG-JEN YU; PAN-CHYR YANG; HUEI-WEN CHEN; WEI J. CHEN; YANG, PAN-CHYRet al. |
| 臺大學術典藏 |
2018-09-10T06:47:50Z |
Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers
|
Chen, J.-P. and Lo, Y. and Yu, C.-J. and Hsu, C. and Shih, J.-Y. and Yang, C.-H.; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T06:47:49Z |
Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation
|
Wu, S.-G. and Shih, J.-Y. and Yu, C.-J. and Yang, P.-C.; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T06:47:48Z |
Incidence and significance of clinically abnormal events in a Tertiary Referral Medical Center: Implementation of the Clinical Alert System (CAS)
|
Jerng, J.-S. and Ko, W.-J. and Lu, F.L. and Chen, Y.-S. and Huang, S.-F. and Yu, C.-J. and Wang, M.-J. and Lin, F.-Y.; JIH-SHUIN JERNG; Chong-Jen Yu; FRANK LEIGH LU |
顯示項目 1011-1035 / 1135 (共46頁)
<< < 36 37 38 39 40 41 42 43 44 45 > >>
每頁顯示[10|25|50]項目
|
